Correlation of brain natriuretic peptide levels in patients with severe aortic stenosis undergoing operative valve replacement or percutaneous transcatheter intervention with clinical, echocardiographic, and hemodynamic factors and prognosis.

[1]  A. Shah,et al.  Successful transcatheter aortic valve implantation (TAVI) is associated with transient left ventricular dysfunction , 2012, Heart.

[2]  R. Lopes,et al.  Natriuretic peptides and long-term mortality in patients with severe aortic stenosis. , 2012, The Journal of heart valve disease.

[3]  G. Dangas,et al.  The predictive value and evolution of N-terminal pro-B-type natriuretic peptide levels following transcutaneous aortic valve implantation. , 2011, Journal of interventional cardiology.

[4]  K. Kent,et al.  Complications and outcome of balloon aortic valvuloplasty in high-risk or inoperable patients. , 2010, JACC. Cardiovascular interventions.

[5]  E. Erdmann,et al.  Utility of NT-pro-BNP in patients undergoing transapical aortic valve replacement , 2010, Clinical Research in Cardiology.

[6]  D. Cokkinos,et al.  Effect of balloon valvuloplasty in patients with severe aortic stenosis on levels of N-terminal pro-B-type natriuretic peptide. , 2009, The American journal of cardiology.

[7]  J. Pepper,et al.  The effect of aortic valve replacement on plasma B‐type natriuretic peptide in patients with severe aortic stenosis — one year follow‐up , 2006, European journal of heart failure.

[8]  W. Little,et al.  Usefulness of an elevated B-type natriuretic peptide in predicting survival in patients with aortic stenosis treated without surgery. , 2005, The American journal of cardiology.

[9]  C. Hamm,et al.  Relation of N-terminal pro B-type natriuretic peptide to progression of aortic valve disease. , 2005, European heart journal.

[10]  J. Garot,et al.  Predictors of outcome in patients with severe aortic stenosis and normal left ventricular function : role of B-type natriuretic peptide ded from , 2004 .

[11]  C. Hamm,et al.  Relation of N-terminal pro-B-type natriuretic peptide to severity of valvular aortic stenosis. , 2004, The American journal of cardiology.

[12]  N. Valli,et al.  Changes in type B natriuretic peptide (BNP) concentrations during cardiac valve replacement. , 2004, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[13]  H. Baumgartner,et al.  Natriuretic Peptides Predict Symptom-Free Survival and Postoperative Outcome in Severe Aortic Stenosis , 2004, Circulation.

[14]  C. Pantos,et al.  Perioperative changes in atrial natriuretic peptide plasma levels associated with mitral and aortic valve replacement. , 2004, Journal of cardiothoracic and vascular anesthesia.

[15]  P. Mathisen,et al.  The effect of aortic valve replacement on N‐terminal natriuretic propeptides in patients with aortic stenosis , 2002, Clinical cardiology.

[16]  I. Palacios,et al.  Three‐Year Outcome After Balloon Aortic Valvuloplast: Insights Into Prognosis of Valvular Aortic Stenosis , 1994, Circulation.